Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | AGXT | P21549 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19057196 | 0.89 | ALDH1A1 (0.56) | ALDH1A1TDP1SLC6A2SLC6A3MAPK1 | |
| SCHEMBL9926611 | 0.81 | ALDH1A1 (0.59) | ALDH1A1TDP1SLC6A2SLC6A3MAPK1 | |
| SCHEMBL7721871 | 0.81 | ALDH1A1 (0.59) | ALDH1A1TDP1SLC6A2SLC6A3MAPK1 | |
| SCHEMBL4246837 | 0.79 | ALDH1A1 (0.56) | ALDH1A1TDP1SLC6A2SLC6A3MAPK1 | |
| SCHEMBL21602399 | 0.79 | ALDH1A1 (0.52) | ALDH1A1TDP1SLC6A2SLC6A3MAPK1 | |
| SCHEMBL3463123 | 0.78 | ALDH1A1 (0.55) | ALDH1A1TDP1SLC6A2SLC6A3MAPK1 | |
| SCHEMBL23899723 | 0.76 | ALDH1A1 (0.53) | ALDH1A1TDP1SLC6A2SLC6A3MAPK1 | |
| SCHEMBL19901925 | 0.76 | ALDH1A1 (0.48) | ALDH1A1TDP1SLC6A2SLC6A3MAPK1 | |
| SCHEMBL8259800 | 0.76 | ALDH1A1 (0.52) | ALDH1A1TDP1SLC6A2SLC6A3MAPK1 | |
| SCHEMBL14530533 | 0.76 | ALDH1A1 (0.52) | ALDH1A1TDP1SLC6A2SLC6A3MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100076199-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDONE CARBOXYLIC ACIDS | GE HEALTHCARE AS (NO) | 2010-03-25 | — | — | US | claimed |
| US-20100076199-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDONE CARBOXYLIC ACIDS | GE HEALTHCARE AS (NO) | 2010-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076199-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED PYRIDONE CARBOXYLIC ACIDS | PNPO, PGD, PDXK | ALDH1A1 1170/4885TDP1 2704/4885SLC6A2 928/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.